Gemcitabine-cisplatin regimen
Term · Oncology and biomedicine · MLC-T-ONC-003459
A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer, advanced bladder cancer, advanced cervical cancer, pancreatic cancer, and epithelial ovarian cancer. It is also being studied in the treatment of other types of cancer. It includes the drugs gemcitabine hydrochloride and cisplatin. Also called gemcitabine-cisplatin.
| Identifier | MLC-T-ONC-003459 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | gemcitabine-cisplatin |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003459",
"term": "Gemcitabine-cisplatin regimen",
"field": "Oncology and biomedicine",
"definition": "A chemotherapy combination used to treat malignant mesothelioma, advanced non-small cell lung cancer, advanced bladder cancer, advanced cervical cancer, pancreatic cancer, and epithelial ovarian cancer. It is also being studied in the treatment of other types of cancer. It includes the drugs gemcitabine hydrochloride and cisplatin. Also called gemcitabine-cisplatin.",
"synonyms": [
"gemcitabine-cisplatin"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/gemcitabine-cisplatin-regimen/"
}
Record 7,872 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.